Bellevue Life Sciences Acquisition Debt to Equity Ratio 1970-1969 | OSRH

Current and historical debt to equity ratio values for Bellevue Life Sciences Acquisition (OSRH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bellevue Life Sciences Acquisition debt/equity for the three months ending December 31, 1969 was 0.00.
Bellevue Life Sciences Acquisition Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
Sector Industry Market Cap Revenue
Unclassified UNCLASSIFIED $0.014B $0.000B
Bellevue Life Sciences Acquisition Corp. is a blank check company. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Bellevue Life Sciences Acquisition Corp. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Tempur Sealy (SGI) United States $11.327B 25.58
FTAC Emerald Acquisition (FLD) United States $0.133B 0.00
PowerUp Acquisition (ASBP) United States $0.048B 0.00
Western Acquisition Ventures (CYCU) United States $0.005B 0.00
Mynaric AG (MYNAY) Germany $0.000B 0.00